26 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:41 PM
Chemo-Pharma Laboratories Ltd.

BSE

  • 22.55 1.05 (4.88%)
  • Vol: 700
  • BSE Code: 506365
  • PREV. CLOSE
    21.50
  • OPEN PRICE
    22.00
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

Chemo-Pharma Laboratories Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
09-Jan-201723-Jan-2017 Quarterly Results
07-Oct-201624-Oct-2016 Quarterly Results
14-Jul-201622-Jul-2016 Unaudited Financial Results
27-May-201630-May-2016 Audited Results & Chemo Pharma Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2016, inter alia, to transact the following business: 1. To consider and approve the Audited Financial Results for the quarter and year ended March 31, 2016, 2. To consider and approve Audited Financial Accounts for the year ended March 31, 2016 duly reviewed by the Audit Committee. 3. To consider and approve Board Report under Section 134 of the Companies Act, 2013. 4. To consider appointment of M/s. Kavita Khatri & Associates as Secretarial Auditor for the Financial Year 2015-2017. 5. To Consider appointment of M/s. Sarda Soni Associates as Internal Auditor for the Financial Year 2016-2017.
06-Jan-201621-Jan-2016 The Board of Directors of the Company will be held on January 21, 2016, to transact the following business: 1. To consider and approve the Un-Audited Financial Results for the quarter ended December 31, 2015. 2. To place and take on record the Limited Review Report on Un-Audited Financial Results for the quarter ended December 31, 2015. 3. To place and consider Uniform Listing Agreement with SEBI as per the reference to the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 and SEBI Circular dated October 13, 2015. 4. To take approval of the Shareholders through Postal Ballot on the following items - a. Adoption of New Articles of Association (Section 14) b. Loan/Guarantee/ Security and Investment by the Company (Section 186) c. Increase in Borrowing Limits of the Company (Section 180 (1) (a) (c)) & Quarterly Results
14-Oct-201527-Oct-2015 Quarterly Results
09-Jul-201523-Jul-2015 Quarterly Results & The Board of Directors of the Company will be held on July 23, 2015, to transact the following business: 1. To consider and approve the Un-Audited Financial Results for the quarter ended June 30, 2015. 2. To place and take on record the Limited Review Report on Un-Audited Financial Results for the quarter ended June 30, 2015. 3. To place and consider the consent letter received from Mr. P. C. Jain for appointment as Additional Director of the Company.
27-May-201528-May-2015 The Board of Directors of the Company will be held on May 28, 2015. inter alia, to transact the following business: 1. To consider and approve the Audited Financial Statements of the Company for the Financial Year Ended March 31, 2015 alongwith Auditors Report thereon. 2. To consider and approve the Audited Financial Results for the year Quarter and Year ended on March 31, 2015. 3. To consider and approve draft Report of Board of Directors and Management Discussion & Analysis Report. 4. To consider and take on record the CEO / CFO Certificate pursuant to Clause 49(V) of the Listing Agreement. 5. To recommend re-appointment of Shri. Ashok Somani, Director of the Company who retires by rotation and, being eligible offers himself for re-appointment. 6. To consider and approve re-appointment of M/s. Batliboi & Purohit, Chartered Accountants as Statutory Auditors of the Company to hold office till conclusion of next Annual General Meeting subject to the approval of the Members of the Company. 7. To recommend regularisation of Smt. Shanta Somani from Additional Director to Director. 8. To give Authority to any of the Director of the Company for Annual Filing of e-forms with Registrar of Companies. 9. To give disclosure of interest / concern in any Companies / body corporate, firms, association of individual by every Director in Form MBP-1. 10. To review the working of the Company. & Audited Results
03-Mar-201516-Mar-2015 A meeting of the Board of Directors of the Company will be held on March 16, 2015, inter alia, to transact the following business: 1. To consider Resignation of Mr. Darsh Mehta from the position Compliance Officer of the Company. 2. To place and take on record the consent letter of Mrs. Neha Vora for appointment of Company Secretary and Compliance Officer of the Company.
08-Jan-201520-Jan-2015 Quarterly Results & The Board of Directors of the Company will be held on January 20, 2015, inter alia, to transact the following business: 1. To Consider and Approve the Un-audited Financial Results for the quarter ended December 31, 2014. 2. To Place and take on record the Limited Review Report on Un-audited Financial Results for the quarter ended December 31, 2014. 3. To Consider and Appoint M/s. S. K. Jain & Co., Practicing Company Secretaries as Secretarial Auditor of the Company as per Section 204 of the Companies Act, 2013. 4. To Consider and Appoint M/s. Sarda Soni & Associates as Internal Auditor of the Company pursuant to the requirement of Section 138 of the Companies Act, 2013.
14-Oct-201421-Oct-2014 Quarterly Results
16-Sep-201426-Sep-2014 The Board of Directors of the Company will be held on September 26, 2014, to transact the following business: 1. To consider and approve the Resignation of Shri. Ashok Joshi from the position of Compliance Officer, Chief Financial Officer and Directorship of the Company. 2. To place and take on record the consent letter of Smt. Shanta Somani for appointment of Additional Director in the Company. 3. To appoint Mr. Darsh Mehta as Compliance Officer of the Company. 4. To consider Change in position of Ashok Somani from the designation of Chief Executive Officer of the Company and appoint him as Chief Financial Officer of the Company. 5. To appoint Smt. Shanta Somani as Chief Executive Officer of the Company.